Home Starget Pharma

Starget Pharma

In operation
Series A
Developer of Peptide-based Radioligand Therapy
Basic
Enterprise Profile

Basic Information

Starget Pharma specializes in the diagnosis and targeted treatment of cancer using targeted radioactive radiation. The company’s research focuses on developing molecules that act as carriers to deliver radioactive isotopes specifically to cancer tumors with unmet medical needs, enabling doctors and healthcare practitioners to provide effective cancer treatments.
Starget Pharma Ltd.
TelAvivDistrict,Israel
less than 15 people
January 01, 2019
--

Enterprise Profile

Industrial Sector
Compound Discovery New Drug Development
Technology
Targeted Technology
Concept
Tumor Therapeutic Products
Application Scenarios
Nuclear Medicine Targeted drugs Innovative Drugs